Patient and Physician Exposure to Artificial Intelligence Hype.

Journal: Pharmacopsychiatry
Published Date: May 12, 2025

Abstract

Both patients and physicians are routinely exposed to the corporate promotion of artificial intelligence (AI) for healthcare products. Hype for AI products may impact both patient behavior and attitudes about healthcare. Corporate AI hype may intentionally overlook the known limitations associated with AI products and focus solely on potential benefits. As AI is increasingly integrated into medicine, physicians are also routinely subject to AI hype. As the promotion and use of AI products have grown dramatically in recent years, physicians should be aware of the potential benefits and risks of AI products despite the hype.

Authors

  • Scott Monteith
    Michigan State University College of Human Medicine, Traverse City Campus, Traverse City, Michigan, USA.
  • Tasha Glenn
    ChronoRecord Association, Fullerton, California, USA.
  • John R Geddes
    Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
  • Peter C Whybrow
    Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles (UCLA), Los Angel es, California, USA.
  • Eric D Achtyes
    Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, USA.
  • Rita Bauer
    Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus Medical Faculty, Technische Universität Dresden, Dresden, Germany.
  • Michael Bauer
    Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus Medical Faculty, Technische Universität Dresden, Dresden, Germany.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals